CD4 and cancer: For SPT cells, previous studies reported controversial results of their prognostic values in different types of cancers.[17] Our result revealed that CD4+SPT cells in T regions were positively associated with OS and RFS, and CD8+SPT cells in T regions were unfavorable to prognosis for HCC patients (Figure S4A, Supporting Information).